Expanding anti-CD38 immunotherapy for lymphoid malignancies.

Wang X, Yu X, Li W, Neeli P, Liu M, Li L, Zhang M, Fang X, Young KH, Li Y

Open source

DOI
10.1186/s13046-022-02421-2
Published
2022 Jun 28
Container
Journal of experimental & clinical cancer research : CR
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13046-022-02421-2,
  title = {Expanding anti-CD38 immunotherapy for lymphoid malignancies.},
  author = {Wang X and Yu X and Li W and Neeli P and Liu M and Li L and Zhang M and Fang X and Young KH and Li Y},
  year = {2022},
  journal = {Journal of experimental \& clinical cancer research : CR},
  doi = {10.1186/s13046-022-02421-2},
  url = {https://doi.org/10.1186/s13046-022-02421-2}
}

RIS

TY  - JOUR
TI  - Expanding anti-CD38 immunotherapy for lymphoid malignancies.
AU  - Wang X
AU  - Yu X
AU  - Li W
AU  - Neeli P
AU  - Liu M
AU  - Li L
AU  - Zhang M
AU  - Fang X
AU  - Young KH
AU  - Li Y
PY  - 2022
JO  - Journal of experimental & clinical cancer research : CR
DO  - 10.1186/s13046-022-02421-2
UR  - https://doi.org/10.1186/s13046-022-02421-2
ER  - 

APA

X, W., X, Y., W, L., P, N., M, L., L, L., M, Z., X, F., KH, Y., & Y, L. (2022). Expanding anti-CD38 immunotherapy for lymphoid malignancies.. Journal of experimental & clinical cancer research : CR. https://doi.org/10.1186/s13046-022-02421-2

Source records